The key difference between tirzepatide and semaglutide is that tirzepatide targets both GLP-1 and GIP
oleifera 's anti-diabetic, anti-sickling, anti-obesity, anti-allergic, anti-atherosclerotic, aphrodisiac, anti-inflammatory, and antihypertensive activities, offering a detailed exploration of its multifaceted health impacts (Jikah & Edo 2023)
Lancet Diabetes Endocrinol.2014;2(4):289-297
Its best to consult your healthcare provider before using it post-surgery
Moreover, studies show a widespread reduction in acetylcholinesterase activity, decreased neuronal arborization and dendritic spine density in specific brain regions of CKD mice
For some kind of comparison, we can look at the US, by far the worlds largest semaglutide market